PMH2 GAPS IN ANTIPSYCHOTIC MEDICATION AND RISK OF HOSPITALIZATION FOR THE TREATMENT OF SCHIZOPHRENIA IN MANAGED CARE SETTINGS
Abstract
Authors
C Kozma J Locklear PJ Weiden
C Kozma J Locklear PJ Weiden
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now